MSF Presses Pharmaceutical Giant to Join HIV Drug Patents Pool

The international medical humanitarian group Medecins San Frontieres has called on a pharmaceutical giant to join a patent pool designed to decrease the prices of HIV medicines and to increase poor people’s access to them.

U.S.-based pharmaceutical company Johnson & Johnson holds patents on three new HIV medicines desperately needed in developing countries but has so far refused to join the Medicines Patent Pool, MSF said, adding that the company’s refusal to participate in the mechanism could undermine access to key HIV drugs.

“By putting its HIV drug patents in the pool, Johnson & Johnson has a unique opportunity to transform this situation and save lives worldwide. Instead, it has chosen to turn its back on these patients,” MSF-USA Executive Director Sophie Delaunay said in an April 25 news release.

MSF is running an online petition urging the company to consider joining the patent pool.

Read more development aid news.

About the author

  • Ivy Mungcal

    As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.